Company Profile

Alan Penn & Associates Inc (AKA: APA Inc~Penn Diagnostics)
Profile last edited on: 2/20/23      CAGE: 46J82      UEI: GJJMTLUFDK77

Business Identifier: Diagnostic feature analysis methods and systems
Year Founded
1986
First Award
1993
Latest Award
2015
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

14 Clemson Court
Rockville, MD 20850
   (301) 279-5958
   apenn@alanpenn.com
   www.alanpenn.com
Location: Single
Congr. District: 08
County: Montgomery

Public Profile

Alan Penn & Associates, Inc. (APA, Inc.) develops diagnostic feature analysis methods and systems that meet the needs of the medical, commercial and industrial communities. The technology underlying APA, Inc. products is an improved method of characterizing the texture of image and signal data. Texture analysis is used in a variety of fields. An important texture characterization is "fractal dimension" or "fd." Standard fd algorithms are effective only when applied to large data sets; when applied to small data sets, such as small or coarsely digitized images, these methods are unreliable. The company’s underlying technology is a method of obtaining reliable fd measurements of small data sets. Primary applications lie in the fields of MRI and mammography. The firm provides training solutions and computer decision support systems to improve the early detection and diagnosis of breast cancer. The technology underlying APA's products is an improved method of characterizing the texture of image and signal data. The technology is applicable to a variety of other medical applications in which it is necessary to discriminate growth patterns likely to lead to complications (e.g., coronary plaque), or are likely to lead to successful drug therapy (bacterial growth colonies). The technology is also applicable to non-medical applications, where there is a need for low-resolution, non-destructive imaging (e.g., industrial MRI), or analysis of small regions-of-interest (e.g., bonding or plating surface)

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2015 2 NIH $1,668,248
Project Title: Novel Diffusion Tensor Imaging CAD for Breast Cancer
2008 1 NIH $100,058
Project Title: Add-On Module For Oncad For Diagnosing Infiltrating Lobular Carcinoma
2005 2 NIH $2,018,172
Project Title: Statistical Surface Fractal Analyzer Of Breast Cancer
2000 2 NIH $798,461
Project Title: Fractal Dimension Features For MRI Breast Mass Analysis
1998 1 NIH $99,996
Project Title: Fractal Features For Diagnosing Mammographic Masses

Key People / Management

  Alan I Penn -- President

  Scott Thompson

Company News

There are no news available.